These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1827023)

  • 1. Management of perioperative hypertension using intravenous isradipine.
    Rüegg PC; Karmann U; Keller H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):203S-206S. PubMed ID: 1827023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of calcium antagonists to treat intra-operative hypertension--evaluation of efficacy and safety of a new dihydropyridine derivative, intravenous isradipine, during abdominal surgery.
    Edouard A; Dartayet B; Ruegg C; Samii K
    Eur J Anaesthesiol; 1991 Sep; 8(5):351-8. PubMed ID: 1834462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter comparison of the safety and efficacy of isradipine and enalapril in the treatment of hypertension.
    Eisner GM; Johnson BF; McMahon FG; Rudd P; Sowers JR; Vargas R; Zemel M
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):154S-157S. PubMed ID: 1827008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
    Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
    Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
    Gómez G; Melgarejo E; Narváez J; Gamarra G; Restrepo G; Acevedo L; Izurieta A
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):128S-130S. PubMed ID: 1827002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure.
    Lacourcière Y; Poirier L; Dion D; Provencher P
    Am J Cardiol; 1990 Feb; 65(7):467-72. PubMed ID: 2137666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled trial of once-a-day isradipine monotherapy in mild to moderately severe hypertension.
    Winer N; Kirkendall WM; Canosa FL; Lewin AJ; McMahon FG; Carr AA; Cohen M
    J Clin Pharmacol; 1990 Nov; 30(11):1006-11. PubMed ID: 2147029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre isradipine dose-confirmation study in Thai patients with hypertension.
    Tanomsup S; Tantbirojn P; Koanantakul B; Nontakanun S; Jaroonvesama N; Charoenlarp K
    Drugs; 1990; 40 Suppl 2():22-5. PubMed ID: 2150635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients.
    Holtzman JL; Abrams A; Cutler R; Hamilton B; Kirkendall WM; Neri G; Stein GH; Matthews KP
    Clin Pharmacol Ther; 1990 Nov; 48(5):590-7. PubMed ID: 2146060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isradipine dose-confirmation study in Filipino patients with mild to moderate hypertension.
    Abarquez RF; Cabral EI; Namin EP; Calleja HB; Porciuncula CI; Divinagracia RA; Anastacio RV; Castillo RR
    Drugs; 1990; 40 Suppl 2():33-7. PubMed ID: 2150639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isradipine twice daily lowers blood pressure over 24 H.
    Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose isradipine once daily effectively controls 24-h blood pressure in essential hypertension.
    Diemont WL; Stegeman CJ; Beekman J; Siegers AM; Hagels G; de Bruijn JH
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):163S-167S. PubMed ID: 1827011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W; Burger KJ; Weidinger G; Welzel D
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
    Wittenberg C; Rosenfeld JB
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):191S-193S. PubMed ID: 1827019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of the blood pressure response to oral isradipine in uncomplicated mild-to-moderate essential hypertension.
    Leary WP; Reyes AJ; Maharaj B; van der Byl K
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):147S-150S. PubMed ID: 1827006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension.
    Sundstedt CD; Rüegg PC; Keller A; Waite R
    Am J Med; 1989 Apr; 86(4A):98-102. PubMed ID: 2523665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
    Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
    Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isradipine for treatment of acute hypertension after myocardial revascularization.
    Brister NW; Barnette RE; Schartel SA; McClurken JB; Alpern J
    Crit Care Med; 1991 Mar; 19(3):334-8. PubMed ID: 1825628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
    Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.